Kelly Cawcutt, MD, MS, FACP, FIDSA: “In a perfect world, vascular access teams and infection prevention teams really should be working very tightly together to optimize the practice of putting our vascular access in place.”
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS, spoke at the HSPA Annual Conference about being survey-ready. Listen…
HSPA’s 2024-2025 president, Anthony Bondon, CRCST, CHL, BSM, AAS, SME, LSSYB, spoke with Infection Control Today to discuss his goals for his tenure and more.
Check out the highlights so far from Infection Control Today at the Healthcare Sterile Processing Association held in Las Vegas, Nevada, from April 20 to…
This presentation by Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL, at HSPA 2024, focuses on understanding and implementing ANSI/AAMI ST79 Amendment 1 to improve…
Tisha Mitsunaga, DrPH, ScM, discusses innovative approaches fostering collaboration between public health and healthcare facilities to combat multidrug-resistant organism (MDRO) spread.
Discover strategies for advocating infection prevention programs to the C-suite, ensuring resources, leadership support, and impactful outcomes.
The FDA has accepted GSK’s BLA for a 5-in-1 meningococcal vaccine candidate, which promises streamlined immunization and a potential reduction in invasive meningococcal disease (IMD).
Hospitals using CDC prevention strategies had different incidences of hospital-associated Clostridioides difficile infection compared to those that didn’t, but the reasons are not necessarily the…
Ramon Zegpi Lagos, DVM, PhD, discusses H5N1 (avian flu), risks, transmission dynamics, preventive measures, and ongoing research at The Ohio State University.
Carole W. Kamangu, MPH, RN, CIC raconte son parcours inspirant depuis la République Démocratique du Congo à son leadership actuel dans le domaine de la…
